Document is current

Article History

Received: 4 November 2024

Accepted: 1 May 2025

First Online: 15 May 2025

Declarations

:

: The study adhered to the principles outlined in the Declaration of Helsinki and the Good Research Practices recommended by the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) []. The study design was registered with the Clinical Research Information Service (CRIS) of South Korea at (KCT0007682) on September 07, 2022 []. The study adhered to STROBE, CONSORT, and CHEERS guidelines (Additional Files 1, 2, and 3). Ethical approval was obtained from the ethical review board of all the following institutions: Mokpo Dongshin University Korean Oriental Hospital (DSMOH-22-04), Daegu Hanny University Hospital (DHUMC-D-22009-AMD-03), Dongguk University Ilsan Oriental Hospital (DHIOH-2022-07-001-004), Kyung Hee University Korean Medicine Hospital (KOMCIRB-2020-03-003-007), Wonkwang University Jeonju Oriental Medicine Hospital (WUJKMH-IRB-2022-007), Chenonan Dosol Korean Oriental Hospital (P01-202011-21-011), Bucheon Jaseng Korean Medicine Hospital (JASENG 2022-08-013-007), Samse Korean Oriental Medical Hospital (P01-202011-21-011), Dong-Eui University Korean Medicine Hospital (DH-2022-10), Woosuk University Jeonju Oriental Medicine Hospital (WSOH-IRB-H2207-03-03), and Kkotdam Hospital of Korean Medicine (P01-202011-21-011). Written informed consent was obtained from all participants.

: Not applicable.

: The authors declare no competing interests.